American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care
https://ascopubs.org/doi/full/10.1200/JCO.20.02953
https://ascopubs.org/doi/full/10.1200/JCO.20.02953
https://meetinglibrary.asco.org/record/186976/slide
https://pubmed.ncbi.nlm.nih.gov/31160171/
https://www.ncbi.nlm.nih.gov/pubmed/30487236 Drilon A, Fu S, Patel MR, Fakih M, Wang D, Olszanski AJ, Morgensztern D, Liu SV, Cho BC, Bazhenova L, Rodriguez CP, Doebele RC,… A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.
Barkley R1, Soobader MJ2, Wang J2, Blau S3, Page RD4.https://www.ncbi.nlm.nih.gov/pubmed/30576262
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e18098
Slamon DJ1, Neven P1, Chia S1, Fasching PA1, De Laurentiis M1, Im SA1, Petrakova K1, Val Bianchi G1, Esteva FJ1, Martín M1, Nusch A1, Sonke GS1, De la Cruz-Merino L1, Beck JT1, Pivot X1, Sondhi M1, Wang Y1, Chakravartty A1, Rodriguez-Lorenc K1, Taran T1, Jerusalem… Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
Piha-Paul SA1, Taylor MH2, Spitz D3, Schwartzberg L4, Beck JT5, Bauer TM6, Meric-Bernstam F1, Purkayastha D7, Karpiak L7, Szpakowski S8, Braiteh F9 https://www.ncbi.nlm.nih.gov/pubmed/31741715